NPM1 and acute myeloid leukemia: To assess the accuracy of both approaches, we compared the MFC-MRD results to the RT-qPCR-based MRD quantification of the NPM1 mutation, a validated and highly sensitive molecular marker for disease monitoring in AML [2,6,20,21,22,23].